Their share price is abysmally low currently at $0.16 and they might be facing delistment this April if they can't bring themselves back up, but on the other hand I hear their clinical trials of cancer immunotherapies might be somewhat promising and their next earning report comes out in March. So maybe they could swing it and with their stock so cheap if by some MIRACLE they could even get back up to their 5-year high of $11.60, then my tiny $50 investment would turn into $3,500. Or If it even reached its more modest 52-week high I'd be sitting on $1,705
Submitted January 13, 2018 at 08:35PM by HorizonZeroD http://ift.tt/2AXwaCK
No comments:
Post a Comment